CXCR4 and neoplasm: Meanwhile, MSCs overexpressing CXCR4, when loaded with chemotherapeutic agents such as paclitaxel, not only preserve their inherent tumor tropism but also substantially boost drug accumulation within the tumor microenvironment (Figure 4) [132,137].